Diversity of lung and spleen immune responses in mice with slowly progressive primary tuberculosis

Scandinavian Journal of Immunology

Volumn 51, Issue 2, 2000, Pages 147-154

  Phyu, S ^a,b,d   Tadesse, A ^a,b   Mustafa, T ^a,b   Tadesse, S ^a,b   Jonsson, R ^b   Bjune, G ^a,c  

^a International Centre for Geohazards   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 4; TUBERCULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; IMMUNE RESPONSE; LUNG; LYMPHOCYTE ACTIVATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIMARY TUBERCULOSIS; PRIORITY JOURNAL; SPLEEN;

ANIMALS; CELLS, CULTURED; CULTURE MEDIA; DISEASE PROGRESSION; FEMALE; INTERFERON TYPE II; INTERLEUKIN-4; LUNG; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MYCOBACTERIUM TUBERCULOSIS; SPLEEN; STEM CELLS; TUBERCULOSIS, PULMONARY;

EID: 0033975788     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00662.x     Document Type: Article

References (44)

1. 1 Mustafa T, Phyu S, Nilsen R, Jonsson R, Bjune G. A mouse model for slowly progressive primary tuberculosis. Scand J Immunol 1999;50:127-36.
2. 2 Medina E, North RJ. Evidence inconsistent with a role for the Bcg gene (Nramp 1) in resistance of mice to infection with virulent Mycobacterium tuberculosis. J Exp Med 1996;183:1045-51.
3. 3 North RJ, Izzo AA. Mycobacterial virulence. Virulent strains of Mycobacterium tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity. J Exp Med 1993;177:1723-33.
4. 4 Phyu S, Sørnes S, Mustafa T, Tadesse A, Jonsson R, Bjune G. Changes in T-lymphocyte subsets in lungs and spleens of mice with slowly progressive primary Mycobacterium tuberculosis infection: Involvement of unconventional T-cell subsets. Scand J Immunol 1999;50:137-44.
5. 5 Turcotte R. Evidence for two distinct populations of suppressor cells in the spleens of Mycobacterium bovis BCG-sensitized mice. Infect Immun 1981;34:315-22.
6. 6 Orme IM, Miller ES, Roberts AD et al. T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens. J Immunol 1992;148:189-96.
7. 7 Apt AS, Kramnik IB, Moroz AM. Regulation of T-cell proliferative responses by cells from solid lung tissue of M. tuberculosis-infected mice. Immunology 1991;73:173-9.
8. 8 Abbas AK, Lichtman AH, Pober JS. Molecular basis of T cell antigen recognition and activation. In: Cellular and Molecular Immunology, 2nd edn. Philadelphia: W.B. Saunders Co, 1994: 137-65.
9. 9 Zeitz M, Quinn TC, Graeff AS, James SP. Mucosal T cells provide helper function but do not proliferate when stimulated by specific antigen in lymphogranuloma venereum proctitis in non-human primates. Gastroenterology 1988;94:353-66.
10. 10 Cohen DA, Fitzpatrick EA, Hartsfield C, Gillespie MM, Avdiushko M, Kaplan AM. Pulmonary lymphoid cell activation and cytokine expression in murine AIDS-associated interstitial pneumonitis. Am J Respir Cell Mol Biol 1997;16:153-61.
11. 11 Lecossier D, Valeyre D, Loiseau A, Battesti J-P, Soler P, Hance AJ. T-lymphocytes recovered by bronchoalveolar lavage from normal subjects and patients with sarcoidosis are refractory to proliferative signals. Am Rev Respir Dis 1988;137:592-9.
12. 12 Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
13. 13 Gerlier D, Thomasset N. Use of MTT colorimetric assay to measure cell activation. J Immunol Methods 1986;94:57-63.
14. + T cell proliferation: Comparison to 5-bromo-2-deoxyuridine (BrdU) ELISA. J Immunol Methods 1999;223:185-94.
15. 15 Ni J, Hollander D. Applications of the MTT assay to functional studies of mouse intestinal intraepithelial lymphocytes. J Clin Lab Anal 1996;10:42-52.
16. 16 Sugawara I, Yamada H, Kazumi Y et al. Induction of granulomas in interferon-γ gene-disrupted mice by avirulent but not by virulent strains of Mycobacterium tuberculosis. J Med Microbiol 1998;47:871-7.
17. 17 Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993;178:2249-54.
18. 18 Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon γ gene-disrupted mice. J Exp Med 1993;178:2243-7.
19. 19 Cardona PJ, Cooper A, Luquín M, Ariza A, Filipo F, Orme IM, Ausina V. The intravenous model of murine tuberculosis is less pathogenic than the aerogenic model owing to a more rapid induction of systemic immunity. Scand J Immunol 1999;49:362-6.
20. 20 Hernández-Pando R, Orozcoe H, Sampieri A et al. Correlation between the kinetics of Th1/Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis. Immunology 1996;89:26-33.
21. 21 Phyu S, Mustafa T, Hofstad T, Nilsen R, Fosse R, Bjune G. A mouse model for latent tuberculosis. Scand J Infect 1998;30:59-68.
22. 22 Nagai S, Wiker HG, Harboe M, Kinomoto M. Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis. Infect Immun 1991;59:372-82.
23. 23 Lin Y, Zhang M, Hofman FM, Gong J, Barnes PF. Absence of a prominent Th2 cytokine response in human tuberculosis. Infect Immun 1996;64:1351-6.
24. 24 Bergeron A, Bonay M, Kambouchner M et al. Cytokine patterns in tuberculous and sarcoid granulomas. Correlations with histopathologic features of the granulomatous response. J Immunol 1997;159:3034-43.
25. 25 Wakeham J, Wang J, Magram J et al. Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis Bacille Calmette-Guérin in IL-12-deficient mice. J Immunol 1998;160: 6101-11.
26. 26 Flynn JL, Bloom BR. Role of Th1 and Th2 cytokines in the response to Mycobacterium tuberculosis. Ann N Y Acad Sci 1996;795:137-46.
27. 27 Sreenivasan P, Misra RS, Wilfred D, Nath I. Lepromatous leprosy patients show T helper 1-like cytokine profile with differential expression of interleukin-10 during type 1 and 2 reactions. Immunology 1998;95:529-36.
28. 28 North RJ. Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis. Clin Exp Immunol 1998;113:55-8.
29. 29 Moreira AL, Tsenova-Berkova L, Wang J et al. Effect of cytokine modulation by thalidomide on the granulomatous response in murine tuberculosis. Tuber Lung Dis 1997;78:47-55.
30. 30 Ellner JJ. The immune response in human tuberculosis - implications for tuberculosis control. J Infect Dis 1997;176:1351-9.
31. 31 Wangoo A, Taylor IK, Haynes AR, Shaw RJ. Up-regulation of alveolar macrophage platelet-derived growth factor-B (PDGF-B) mRNA by interferon-gamma from Mycobacterium tuberculosis antigen (PPD)-stimulated lymphocytes. Clin Exp Immunol 1993;94:43-50.
32. 32 Ellner JJ. Regulation of the human immune response during tuberculosis. J Lab Clin Med 1997;130:469-75.
33. 33 Sibley LD, Hunter SW, Brennan PJ, Krahenbuhl JL. Mycobacterial lipoarabinomannan inhibits gamma interferon-mediated activation of macrophages. Infect Immun 1988;56:1232-6.
34. 34 Flesch IEA, Kaufmann SHE. Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumour necrosis factor. Infect Immun 1990;58:2675-7.
35. 35 Denis M, Gregg EO. Modulation of Mycobacterium avium growth in murine macrophages: Reversal of unresponsiveness to interferon-gamma by indomethacin or interleukin-4. J Leukoc Biol 1991;49:65-72.
36. 36 McInnes A, Rennick DM. Interleukin 4 induces cultured monocytes/ macrophages to form giant multinucleated cells. J Exp Med 1988;167:598-611.
37. 37 Méndez-Samperio P, Hernandez-Garay M, Badillo-Flores A, Nuñez-Vazquez A. Down-modulation of mycobacterial-induced IL-1β production in human mononuclear cells by IL-4. Clin Exp Immunol 1996;104:374-9.
38. 38 Yamamura M, Uyemura K, Deans RJ et al. Defining protective responses to pathogens: Cytokine profiles in leprosy lesions. Science 1991;254:277-9.
39. 39 Hart PH, Ahern MJ, Jones CA, Jones KL, Smith MD, Finlay-Jones JJ. Synovial fluid macrophages and blood monocytes differ in their response to IL-4. J Immunol 1993;151:3370-80.
40. 40 Hirsch CS, Toossi Z, Vanham G et al. Apoptosis and T cell hyporesponsiveness in pulmonary tuberculosis. J Infect Dis 1999;179:945-53.
41. 41 Torres M, Herrera T, Villareal H, Rich EA, Sada E. Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30-kilodalton antigen of Mycobacterium tuberculosis. Infect Immun 1998;66:176-80.
42. 42 Surcel H-M, Troye-Blomberg M, Paulie S et al. Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 1994;81:171-6.
43. 43 Klausen J, Magnusson M, Andersen ÅB, Koch C. Characterization of purified protein derivative of tuberculin by use of monoclonal antibodies: Isolation of a delayed-type hypersensitivity reactive component from M. tuberculosis culture filtrate. Scand J Immunol 1994;40:345-9.
44. 44 Wiker HG, Harboe M. The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev 1992;56:648-61.